LONDON, Aug. 23, 2014 /PRNewswire/ — ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.1 Triumeq is …
Read MoreTag: FDA
Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices
NORTHBROOK, Ill., July 22, 2014 /PRNewswire/ — UL (Underwriters Laboratories), a global safety science leader, has announced that the U.S. Food and Drug Administration (FDA) has recognized two UL battery safety standards as consensus standards for medical devices incorporating …
Read MoreIBA Receives FDA Approval of its New Compact Gantry Clearing the Way for Proteus®ONE
LOUVAIN-LA-NEUVE, Belgium, July 16, 2014 /PRNewswire/ — IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has received Marketing Authorization from the U.S. Food and …
Read More